KB Financial Partners’s AstraZeneca AZN Stock Holding History

KB Financial Partners’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$520K	Buy	3,842 +1	+0%	+$137	0.15%	86
2023 Q2	$550K	Buy	3,841 +3,486	+982%	+$513K	0.15%	78
2023 Q1	$49K	Sell	355 -169	-32%	-$22.7K	0.01%	260
2022 Q4	$71K	Buy	524 +73	+16%	+$9.15K	0.02%	235
2022 Q3	$49K	Buy	451 +436	+2,907%	+$55.3K	0.02%	246
2022 Q2	$2K	Hold	15	–	–	﹤0.01%	488
2022 Q1	$2K	Hold	15	–	–	﹤0.01%	536
2021 Q4	$2K	Buy	+15	New	+$1.76K	﹤0.01%	571

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

KB Financial Partners's AZN Position: Q3 2023 in Review

KB Financial Partners increased its AstraZeneca (AZN) stake by 0.03% in Q3 2023, buying an estimated $137 and bringing the position to 3,842 shares worth $520K. The position accounts for 0.15% of the portfolio, ranked #86.

KB Financial Partners first reported a position in AZN in Q4 2021 and has held it in 8 quarters since. The position peaked at $550K in Q2 2023. 1,074 funds tracked by Wall St. Rank hold AZN as of Q3 2023.

KB Financial Partners held 3,842 shares of AstraZeneca worth $520K as of Q3 2023.
KB Financial Partners bought 1 AstraZeneca share in Q3 2023, an estimated $137.
AstraZeneca made up 0.15% of KB Financial Partners's portfolio in Q3 2023, its #86 holding.
KB Financial Partners first reported a position in AstraZeneca in Q4 2021 and has held it in 8 quarters since.
KB Financial Partners's AstraZeneca position peaked at $550K in Q2 2023.
1,074 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2023.

Based on KB Financial Partners's 13F filing for Q3 2023, filed 15 Nov 2023.